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S54 Lupus Nephropathybut tended to present a higher prevalence of fever, acute kidney injury,
oliguria or anuria. During a median follow-up of 55.0 months, 107
(12.2%) patients had doubling of serum creatinine or ESRD (male 7.9% vs
female 8.5%) and 114 (13.0%) patients died (male 14.9% vs female 7.8%).
Regarding patient survival, compared with female patients, males had
no difference in renal outcome but had significantly higher mortality
than females.
Conclusion: The male lupus nephritis patients had worse renal function
compared with female patients. Moreover, male patients had significantly
higher mortality.http://dx.doi.org/10.1016/j.hkjn.2015.08.139
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Background: Renal proximal tubular epithelial cells (PTEC) and T lympho-
cytes assume pathogenic roles in tubulointerstitial inflammation in lupus
nephritis (LN). Their interaction in such inflammatory process remains
unclear.
Methods: CD4+ and CD8+ T cells were isolated from LN patients with (Group
I) or without (Group II) moderate to severe tubulointerstitial inflammation,
and co-incubated with PTEC in a transwell system. The level of cytokines
in the culture media were measured after 72 hours of co-culture and
compared between Group I and II patients.
Results: Twelve proliferative LN patients with (Group I; n Z 7) or without
(Group II; n Z 5) moderate to severe tubulointerstitial inflammation were
included. Group I patients showed significantly higher levels of RANTES
(p Z 0.002, 0.015 and 0.014) but lower IL-10 (p Z 0.018, 0.015 and 0.022)
when PTEC were co-cultured with their CD4+ T cells, CD8+ T cells or with
both CD4+ and CD8+ T cells. Group I also demonstrated higher levels of
MCP-1 (p Z 0.016 and 0.042) when PTEC were co-cultured with their CD8+
T cells or with both CD4+ and CD8+ T cells. There is no statistically significant
difference in IL-6 or IL-8, although Group I showed numerically much higher
IL-6 levels.
Conclusion: A significant increase in RANTES and MCP-1 and a decrease in IL-
10 levels were observed upon PTEC/T cell interaction in LN patients with
moderate to severe tubulointerstitial inflammation, and hence suggest the
putative roles of these cytokines in mediating tubulointerstitial inflamma-
tion in LN.http://dx.doi.org/10.1016/j.hkjn.2015.08.140
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Objective: Repeated renal flares jeopardize the long-term kidney function
in lupus nephritis (LN) patients. This study investigated the risk factors for
relapse in the era of effective immunosuppressive treatments.
Methods: All LN patients who were followed up in Queen Mary Hospital dur-
ing the period of 1 January 1983 to 31 December 2013 were reviewed. Epi-
sodes of renal relapses were identified and the risk factors for relapse
were analyzed. The risk of relapse was also analyzed according to the era
before (1983e1997) and after (1998e2013) the availability of mycophenolic
acid (MPA) treatment in our centre.Results: A total of 346 episodes of renal flares occurred in 184 patients (mean
follow-up duration 195.3  94.4 months). Multivariate analysis showed that
age (OR 0.97; 95% CI 0.943e0.998; pZ 0.038), higher serum creatinine on pre-
sentation (OR 0.992; 95% CI 0.985e0.999; PZ 0.019),use of mycophenolic acid
(MPA) as maintenance treatment (OR 0.322; 95% CI 0.0109e0.953; PZ 0.041)
and achievement of complete remission after induction therapy (OR 0.394;
95% CI 0.175e0.886; PZ 0.024) were factors associated with lower risk of renal
relapse. The choice of induction therapy, proteinuria and serological parame-
ters on presentation did not affect the risk of subsequent flares (all P> 0.05).
Rates of renal relapse were 0.044 and 0.024 relapse per patient-year before
and after the availability of MPA treatment (P< 0.001). Patients who received
prednisolone and MPA maintenance showed better relapse-free survival those
on prednisolone and azathioprine (AZA) (83% vs. 68%, 66% vs. 42% and 62% vs.
37% at 5, 10 and 15 years; PZ 0.048).
Conclusion: The risk of renal flare was low in the era of effective immuno-
suppressive treatments. The use of MPA as maintenance treatment might
have contributed to lower risk of LN relapse and appeared to be more effec-
tive than AZA to prevent flares.http://dx.doi.org/10.1016/j.hkjn.2015.08.141
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Objective: To compare the level of annexin II in patients with systemic lupus
erythematosus, diabetic nephropathy, chronic glomerulonephritis and in
normal control group, to explore the significance of the annexin II in sys-
temic lupus erythematosus.
Methods: Thirty-five cases of patients with systemic lupus erythematosus,
10 cases of patients with diabetic nephropathy, and 10 cases of patients
with chronic glomerulonephritis were enrolled in this study; 20 cases of
healthy controls were also enrolled. Circulating annexin II in white blood
cells was detected by flow cytometry. Student’s t test, variance analysis
and linear correlation analysis were used for statistics.
Results: Compared with healthy control cases, the level of annexin II in
white blood cells in SLE patients (7.10  2.89%) and DN patients
(7.95  3.72%) were significantly lower than that in healthy controls
(P< 0.01, P< 0.05). In the SLE group, the level of annexin II in patients
who were more active (SLEDAI  9) decreased more than in those who
were less active (SLEDAI < 9; P< 0.05). As for annexin II, a positive correla-
tion was found with serum albumin (rZ 0.439, p< 0.01), negtive correlation
was found with urine protein/urine creatinine (r Z 0.382, p< 0.05), SLE-
DAI (r Z 0.417, p< 0.05), and D-dimer (r Z 0.336, p< 0.05).
Conclusion: The level of annexin II is decreased in patients with systemic
lupus erythematosus. It can be used as a reflection of the abnormality of
the coagulation and fibrinolytic systems. It may be used as a good indicator
of the prothrombotic state in SLE patients, and be helpful in judging the ac-
tivity and therapeutic effect of the disease.http://dx.doi.org/10.1016/j.hkjn.2015.08.142
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Objectives: To analyze and compare the effects of rituximab (RTX) and
cyclophosphamide (CTX) on the serum levels of anti-C1q antibodies and
